Detailed financial statements for The Chemours Company (CC): income statement, balance sheet and cash-flow summary. Track margins, debt, liquidity and profitability trends year over year: ten fiscal years free and up to 20 with Premium.
The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. The company operates through three segments: Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials. The Thermal & Specialized Solutions segment provides refrigerants, thermal management solutions, propellants, foam blowing agents, and specialty solvents under the Freon and Opteon brand names.
Analysis Summary
The Chemours Company reported revenue of $5.81B in the most recent fiscal year, growing at a 5-year CAGR of 3.2%.
Trailing-twelve-month margins: gross margin 15.3%, operating margin -5.2%, net margin -5.2%. Free cash flow grew at -37.6% CAGR over 5 years.
At $13.53 (closing price, October 30, 2026), CC has negative trailing earnings (P/E not meaningful) and an ROE of -170.31%. Market capitalisation stands at $2.0B.
Balance sheet quality for CC: debt-to-equity ratio of -84.08, current ratio of 1.66 over the last 12 months, net debt of $3.91B at the end of the last fiscal year. A debt-to-equity below 1.0 typically signals conservative capital structure, while a current ratio above 1.5 indicates comfortable short-term liquidity.
Income Statement (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.40B | $6.18B | $6.64B | $5.53B | $4.97B | $6.34B | $6.83B | $6.08B | $5.78B | $5.81B |
| Cost of Revenue | $4.29B | $4.43B | $4.67B | $4.46B | $3.90B | $4.96B | $5.21B | $4.77B | $4.63B | $4.91B |
| Gross Profit | $1.11B | $1.75B | $1.97B | $1.06B | $1.07B | $1.38B | $1.62B | $1.31B | $1.15B | $902.0M |
| Research & Development | $80.0M | $80.0M | $82.0M | $80.0M | $93.0M | $107.0M | $118.0M | $108.0M | $109.0M | $108.0M |
| Selling, General & Admin | $934.0M | $602.0M | $657.0M | 0 | 0 | $592.0M | $710.0M | $1.29B | $585.0M | $799.0M |
| Operating Expenses | $1.01B | $682.0M | $739.0M | $616.0M | $619.0M | $707.0M | $830.0M | $1.43B | $708.0M | $907.0M |
| Operating Income | $96.0M | $1.07B | $1.23B | $447.0M | $448.0M | $674.0M | $786.0M | -$123.0M | $443.0M | -$5.0M |
| EBITDA | $715.0M | $1.34B | $1.54B | $758.0M | $767.0M | $1.18B | $1.20B | $197.0M | $692.0M | $332.0M |
| Interest Expense | $219.0M | $215.0M | $195.0M | $208.0M | $210.0M | $185.0M | $163.0M | $208.0M | $264.0M | $269.0M |
| Pre-tax Income | -$11.0M | $912.0M | $1.16B | $20.0M | $179.0M | $676.0M | $741.0M | -$318.0M | $127.0M | -$277.0M |
| Income Tax | -$18.0M | $165.0M | $159.0M | $72.0M | -$40.0M | $68.0M | $163.0M | -$81.0M | $41.0M | $109.0M |
| Net Income | $7.0M | $746.0M | $995.0M | -$52.0M | $219.0M | $608.0M | $578.0M | -$238.0M | $86.0M | -$386.0M |
| EPS | $0.04 | $4.04 | $5.62 | -$0.32 | $1.33 | $3.69 | $3.72 | -$1.60 | $0.58 | -$2.57 |
| EPS (Diluted) | $0.04 | $3.91 | $5.45 | -$0.32 | $1.32 | $3.60 | $3.65 | -$1.60 | $0.57 | -$2.56 |
| Shares Outstanding (Diluted) | 183.4 M | 191.0 M | 182.6 M | 164.8 M | 166.3 M | 168.7 M | 158.3 M | 148.9 M | 150.0 M | 150.6 M |
Income Statement (Quarterly)
| Year | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|---|---|---|---|
| Revenue | $1.50B | $1.33B | $1.38B | $1.59B |
| Gross Profit | $235.0M | $153.0M | $215.0M | $286.0M |
| Operating Income | $104.0M | -$259.0M | $64.0M | -$213.0M |
| EBITDA | $198.0M | -$76.0M | $125.0M | -$413.0M |
| Net Income | $60.0M | -$61.0M | -$29.0M | -$274.0M |
| EPS | $0.40 | -$0.40 | -$0.19 | -$1.81 |
| EPS (Diluted) | $0.40 | -$0.39 | -$0.19 | -$1.81 |
Balance Sheet (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $902.0M | $1.56B | $1.20B | $943.0M | $1.10B | $1.45B | $1.10B | $1.20B | $713.0M | $672.0M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | $807.0M | $919.0M | $861.0M | $674.0M | $511.0M | $720.0M | $626.0M | $610.0M | $770.0M | $679.0M |
| Inventory | $767.0M | $935.0M | $1.15B | $1.08B | $939.0M | $1.10B | $1.40B | $1.35B | $1.47B | $1.57B |
| Total Current Assets | $2.55B | $3.49B | $3.29B | $2.78B | $2.63B | $3.35B | $3.21B | $3.83B | $3.03B | $3.00B |
| Property, Plant & Equipment | $2.78B | $3.01B | $3.29B | $3.85B | $3.71B | $3.38B | $3.41B | $3.48B | $3.44B | $3.35B |
| Goodwill | $153.0M | $153.0M | $153.0M | $153.0M | $153.0M | $102.0M | $102.0M | $102.0M | $46.0M | $46.0M |
| Intangible Assets | $17.0M | $13.0M | $28.0M | $21.0M | $14.0M | $6.0M | $13.0M | $3.0M | $3.0M | $2.0M |
| Total Assets | $6.06B | $7.29B | $7.36B | $7.26B | $7.08B | $7.55B | $7.64B | $8.25B | $7.51B | $7.38B |
| Accounts Payable | $884.0M | $1.07B | $1.14B | $901.0M | $820.0M | $1.14B | $1.21B | $1.13B | $1.12B | $929.0M |
| Short-term Debt | $15.0M | $15.0M | $13.0M | $134.0M | $21.0M | $25.0M | $43.0M | $51.0M | $54.0M | $104.0M |
| Total Current Liabilities | $1.77B | $1.65B | $1.71B | $1.54B | $1.44B | $1.86B | $1.89B | $2.49B | $1.80B | $1.69B |
| Long-term Debt | $3.53B | $4.10B | $3.96B | $4.03B | $4.00B | $3.72B | $3.59B | $3.94B | $4.02B | $4.26B |
| Total Liabilities | $5.96B | $6.43B | $6.34B | $6.56B | $6.27B | $6.47B | $6.53B | $7.51B | $6.91B | $7.13B |
| Retained Earnings | -$114.0M | $579.0M | $1.47B | $1.25B | $1.30B | $1.75B | $2.17B | $1.78B | $1.72B | $1.22B |
| Total Equity | $100.0M | $860.0M | $1.01B | $689.0M | $813.0M | $1.08B | $1.11B | $737.0M | $604.0M | $250.0M |
| Total Debt | $3.54B | $4.11B | $3.97B | $4.47B | $4.28B | $3.99B | $3.88B | $4.30B | $4.36B | $4.58B |
| Net Debt | $2.64B | $2.56B | $2.77B | $3.53B | $3.17B | $2.54B | $2.78B | $3.10B | $3.64B | $3.91B |
| Working Capital | $782.0M | $1.84B | $1.58B | $1.24B | $1.19B | $1.49B | $1.32B | $1.35B | $1.22B | $1.31B |
Balance Sheet (Quarterly)
| Year | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|---|---|---|---|
| Cash & Equivalents | $613.0M | $670.0M | $563.0M | $671.0M |
| Total Assets | $7.57B | $7.38B | $7.27B | $7.15B |
| Total Liabilities | $7.27B | $7.13B | $7.05B | $7.20B |
| Total Equity | $298.0M | $250.0M | $215.0M | -$49.0M |
| Total Debt | $4.42B | $4.58B | $4.39B | $4.12B |
Cash Flow (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | $7.0M | $747.0M | $996.0M | -$52.0M | $219.0M | $608.0M | $578.0M | -$238.0M | $86.0M | -$386.0M |
| Depreciation & Amortization | $284.0M | $273.0M | $284.0M | $311.0M | $320.0M | $317.0M | $291.0M | $307.0M | $301.0M | $340.0M |
| Stock-based Compensation | $19.0M | $29.0M | $24.0M | $19.0M | $16.0M | $34.0M | $27.0M | $19.0M | $15.0M | $21.0M |
| Change in Working Capital | $484.0M | -$466.0M | -$206.0M | $138.0M | $356.0M | $21.0M | -$103.0M | $620.0M | -$1.05B | $178.0M |
| Operating Cash Flow | $594.0M | $639.0M | $1.14B | $650.0M | $807.0M | $814.0M | $755.0M | $556.0M | -$633.0M | $264.0M |
| Capital Expenditure | -$338.0M | -$411.0M | -$498.0M | -$481.0M | -$267.0M | -$277.0M | -$307.0M | -$370.0M | -$360.0M | -$213.0M |
| Acquisitions | -$1.0M | $39.0M | -$37.0M | -$10.0M | $5.0M | 0 | 0 | 0 | 0 | $7.0M |
| Stock Repurchased | 0 | -$106.0M | -$644.0M | -$322.0M | -$2.0M | -$173.0M | -$495.0M | -$69.0M | 0 | -$1.0M |
| Dividends Paid | -$22.0M | -$22.0M | -$148.0M | -$164.0M | -$164.0M | -$164.0M | -$154.0M | -$149.0M | -$148.0M | -$78.0M |
| Free Cash Flow | $256.0M | $228.0M | $642.0M | $169.0M | $540.0M | $537.0M | $448.0M | $186.0M | -$993.0M | $51.0M |
Cash Flow (Quarterly)
| Year | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|---|---|---|---|
| Operating Cash Flow | $146.0M | $137.0M | -$44.0M | $114.0M |
| Capital Expenditure | -$41.0M | -$45.0M | -$49.0M | -$93.0M |
| Free Cash Flow | $105.0M | $92.0M | -$93.0M | $21.0M |
| Dividends Paid | -$13.0M | -$15.0M | -$13.0M | -$26.0M |
| Stock-based Compensation | $5.0M | 0 | $7.0M | $14.0M |
Growth & Margins (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue Growth (YoY) | +14.5% | +7.4% | -16.8% | -10.1% | +27.7% | +7.7% | -11.0% | -4.9% | +0.4% | |
| Net Income Growth (YoY) | +10,557.1% | +33.4% | -105.2% | +521.2% | +177.6% | -4.9% | -141.2% | +136.1% | -548.8% | |
| EPS Growth (YoY) | +10,000.0% | +39.1% | -105.7% | +515.6% | +177.4% | +0.8% | -143.0% | +136.2% | -543.1% | |
| Shares Change (YoY) | +4.1% | -4.4% | -9.7% | +0.9% | +1.4% | -6.2% | -5.9% | +0.7% | +0.4% | |
| FCF Growth (YoY) | -10.9% | +181.6% | -73.7% | +219.5% | -0.6% | -16.6% | -58.5% | -633.9% | +105.1% | |
| Gross Margin | 20.6% | 28.4% | 29.7% | 19.2% | 21.5% | 21.8% | 23.7% | 21.5% | 19.9% | 15.5% |
| Operating Margin | 1.8% | 17.3% | 18.6% | 8.1% | 9.0% | 10.6% | 11.5% | -2.0% | 7.7% | -0.1% |
| EBITDA Margin | 13.2% | 21.8% | 23.2% | 13.7% | 15.4% | 18.6% | 17.5% | 3.2% | 12.0% | 5.7% |
| Net Margin | 0.1% | 12.1% | 15.0% | -0.9% | 4.4% | 9.6% | 8.5% | -3.9% | 1.5% | -6.6% |
| FCF Margin | 4.7% | 3.7% | 9.7% | 3.1% | 10.9% | 8.5% | 6.6% | 3.1% | -17.2% | 0.9% |
| Effective Tax Rate | 163.6% | 18.1% | 13.8% | 360.0% | -22.3% | 10.1% | 22.0% | 25.5% | 32.3% | -39.4% |
Per-Share Data (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| FCF Per Share | $1.40 | $1.19 | $3.52 | $1.03 | $3.25 | $3.18 | $2.83 | $1.25 | -$6.62 | $0.34 |
| Dividends Per Share | $0.12 | $0.12 | $0.81 | $1.00 | $0.99 | $0.97 | $0.97 | $1.00 | $0.99 | $0.52 |
| Shares Outstanding (Basic) | 181.6 M | 184.8 M | 177.0 M | 164.8 M | 164.7 M | 164.9 M | 155.4 M | 148.9 M | 149.5 M | 150.4 M |
What to look at in Basic Materials
Miners, chemicals, steel. 100% commodity-driven. Analysing them with pure P/E is a mistake — look at cost position and dividend sustainability.
- FCF yield — In commodities FCF is gold — EPS is very misleading
- Gross margin — 5y consistent gross margin = moat signal
- Net debt / EBITDA (trough) — Use EBITDA from the worst year of the cycle, not the current one
- Dividend coverage — Dividend covered by FCF in an average year, not at peak
- Capex / D&A — >1x = maintain/grow reserves. <0.7x = decapitalising
- Altman Z-Score — Bankruptcy model (NYU 1968) — combines liquidity, leverage and profitability. Key in cyclicals
- P/B across cycles — Commodities: 0.8-1.2x at troughs, 2x+ at peaks. <2x still reasonable zone
Profitability
| Return on Equity | -170.31% |
| Return on Invested Capital | -5.65% |
| Return on Assets | -4.25% |
| Gross Margin | 15.34% |
| Operating Margin | -5.24% |
| Net Margin | -5.24% |
Financial Health
| Debt / Equity | -84.08 |
| Current Ratio | 1.66 |
| Piotroski F-Score | 4 |
| Altman Z-Score | 1.38 |
Key Ratios (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| P/E | 552.25 | 12.39 | 5.02 | -56.53 | 18.64 | 9.09 | 8.23 | -19.71 | 29.14 | -4.59 |
| P/B | 40.12 | 10.76 | 4.93 | 4.33 | 5.02 | 5.12 | 4.30 | 6.37 | 4.18 | 7.09 |
| P/S | 0.74 | 1.50 | 0.75 | 0.54 | 0.82 | 0.87 | 0.70 | 0.77 | 0.44 | 0.31 |
| Gross Margin | 20.6% | 28.4% | 29.7% | 19.2% | 21.5% | 21.8% | 23.7% | 21.5% | 19.9% | 15.5% |
| Operating Margin | 1.8% | 17.3% | 18.6% | 8.1% | 9.0% | 10.6% | 11.5% | -2.0% | 7.7% | -0.1% |
| Net Margin | 0.1% | 12.1% | 15.0% | -0.9% | 4.4% | 9.6% | 8.5% | -3.9% | 1.5% | -6.6% |
Related companies: LIN · APD · PPG · LYB · IFF · ESI · AXTA · CBT
Explore sector: Basic Materials · Chemicals - Specialty
More sections of CC: Overview · Valuation · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Companies that pass the Buffett method · Companies that pass the Lynch method · Stocks that pass Graham's defensive investor test today · Investment Academy — learn to analyze stocks